Cheaper HIV/AIDS Medication On The Way

Friday, August 7 | posted in | 0 comments

Our first blackPresident Bill Clinton and drug company Pfizer and Matrix Laboratories Ltd announced a deal to lower the cost of treatments for patients with drug-resistant forms of HIV/AIDS.

Second-line antiretroviral therapies and a drug used to treat tuberculosis for those with drug-resistant HIV/AIDS will be made available at a reduced cost and in more convenient regimens, saving as many as hundreds of thousands of lives in the developing world, Clinton said.

"Today's announcement will help ensure we can sustain treatment over a lifetime and better treat patients with both HIV and TB, two key steps in turning the tide of the global HIV/AIDS pandemic,"

Starting in 2010, Matrix, a unit of U.S.-based Mylan Inc, will make four drugs available at a cost of $425 per year. The discount will result in $400 million in savings over the next five years compared to prices commonly paid for alternative regimens.

Matrix said it would create a more convenient regimen for taking the drugs, allowing patients to take pills just once per day.

Pfizer will offer the tuberculosis drug rifabutin in 10 countries for $1 per dose, or $90 for a full course of treatment over six months.

Let me just say that even out of office Clinton is just handling business!

Source: Reuters

0 Responses So far

Post a Comment

Recent Posts

Warm & Tasty



    Show your pride for the Warm And Tasty Blog by adding this button to whatever social networking site you are on!